Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intermediate-risk Prostate Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01596816
What this trial is testing

Hypofractionated Stereotactic Boost in Prostate Cancer

Who this might be right for
Cancer
Centre Oscar Lambret 76
Large-scale testing (Phase 3)UnknownNCT06011304
What this trial is testing

Study of 18F-Florastamin PET/CT Imaging in Patients With at Least Intermediate Risk Prostate Cancer

Who this might be right for
Prostate Cancer
HTA Co., Ltd. 267
Not applicableNot Yet RecruitingNCT07492381
What this trial is testing

A Prospective, Single-Arm, Pilot Study of the ALPFA BPH PFA System in Men With Low, Intermediate and High-Risk Prostate Cancer

Who this might be right for
Prostate Cancer
ALPFA Medical 50
Early research (Phase 1)Study completedNCT02064608
What this trial is testing

Investigating the Effects of AZD2014 Therapy Given Prior to Radical Prostatectomy in Men With High Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Cambridge University Hospitals NHS Foundation Trust 23
Large-scale testing (Phase 3)Study completedNCT00936390
What this trial is testing

Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 1,538
Testing effectiveness (Phase 2)Looking for participantsNCT05346848
What this trial is testing

Randomized Phase II Trial on Short Term Darolutamide Concomitant to Radiation Therapy for Patients With Intermediate Unfavorable Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Institut Bergonié 62
Not applicableLooking for participantsNCT04831983
What this trial is testing

ABlative Radiotherapy (for) Unfavorable Prostate Tumors

Who this might be right for
Prostate Cancer
University of Milano Bicocca 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07152067
What this trial is testing

Stereotactic Focal Radiotherapy as an Alternative Treatment to Active Surveillance for Low and Intermediate Risk Prostate Cancer

Who this might be right for
Macroscopic Tumor Visualized at MRITumor Size Allowing Partial Prostate Treatment VolumeCAPRA SCORE ≤5
Centre Hospitalier Universitaire de Liege 146
Not applicableActive Not RecruitingNCT04985565
What this trial is testing

Neoadjuvant Dietary Intervention in Intermediate Risk Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaStage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8+4 more
M.D. Anderson Cancer Center 12
Testing effectiveness (Phase 2)Ended earlyNCT04727736
What this trial is testing

18F-DCFPyL Positron Emission Tomography (PET) in Intermediate or High Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Ashok Muthukrishnan 47
Testing effectiveness (Phase 2)Ended earlyNCT01039038
What this trial is testing

Feasibility Study of a Dose Increase by a Boost of Curietherapy in Pulse Dose Rate (PDR) Associated With the Extern Radiotherapy in Prostate Cancer

Who this might be right for
Prostate Cancer With Intermediate Risk
Centre Francois Baclesse 50
Not applicableUnknownNCT04870567
What this trial is testing

HDR Brachytherapy vs SABR in Early-intermediate Prostate Cancer

Who this might be right for
Biochemical Relapse Free SurvivalComplications Rates (Erectile Dysfunction, GI, GU Complications)
N.N. Petrov National Medical Research Center of Oncology 350
Large-scale testing (Phase 3)Looking for participantsNCT07548164
What this trial is testing

Comparing Two Different Boost Approaches in Radiation Therapy for People With Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 224
Not applicableStudy completedNCT04972097
What this trial is testing

Pivotal Study of the NanoKnife System for the Ablation of Prostate Tissue

Who this might be right for
Prostate Cancer
Angiodynamics, Inc. 121
Early research (Phase 1)WithdrawnNCT01826838
What this trial is testing

Study of Dasatinib, Androgen Deprivation Therapy and Radiation

Who this might be right for
Prostate Cancer
Brown University
Testing effectiveness (Phase 2)UnknownNCT03924466
What this trial is testing

Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma Patients

Who this might be right for
Metastatic Breast CarcinomaLocally Advanced Breast CancerCancer of Pancreas+11 more
Universitair Ziekenhuis Brussel 55
Post-approval studies (Phase 4)Study completedNCT01296672
What this trial is testing

3 Month Finasteride Challenge Test Can Significantly Improve the Performance of Screening for Prostate Cancer

Who this might be right for
Prostate Cancer
The University of Texas Health Science Center at San Antonio 383
Not applicableStudy completedNCT00573833
What this trial is testing

Internal Radiation Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 23
Not applicableActive Not RecruitingNCT00890006
What this trial is testing

Advanced Imaging for Radiotherapy Treatment Planning and Guidance for Low-Intermediate Risk Prostate Cancer (Margin)

Who this might be right for
Low or Intermediate Risk Prostate Cancer
University Health Network, Toronto 99
Not applicableStudy completedNCT04307056
What this trial is testing

Evaluation of HIFU in TREATMENT OF LOCALIZED PROSTATE CANCER and OF RECURRENCE AFTER RADIOTHERAPY

Who this might be right for
Prostate CancerUltrasound Therapy
Association Francaise d'Urologie 3,862
Next Page